MLTX
MoonLake ($MLTX): From Collapse to Recovery Play—The Nanobody Rebound Story
The Fall from Grace: A 90% Overnight Collapse On September 28, 2025, MoonLake Immunotherapeutics (NASDAQ: MLTX) experienced one of biotech's most dramatic single-day collapses in recent memory. The stock plummeted 90%—from $62 to as low as $5.95—as the company announced results from its Phase 3